Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety

Psychiatr Clin North Am. 2005 Dec;28(4):941-83, ix-x. doi: 10.1016/j.psc.2005.09.002.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Aged
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Humans
  • Neurodegenerative Diseases / psychology*
  • Psychomotor Agitation / drug therapy*
  • Psychomotor Agitation / etiology*
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / etiology*
  • Treatment Outcome

Substances

  • Antipsychotic Agents